Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$56.48
0.430.77%
Last update: Oct 2, 4:00 PM
$56.48
0.430.77%
Vaxcyte Inc (PCVX) Stock Price, Quote, News & History
PCVXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Vaxcyte (NASDAQ:PCVX) through any online brokerage.
Other companies in Vaxcyte’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Vaxcyte has a consensus price target of $120.30.
The stock price for Vaxcyte (NASDAQ: PCVX) is $56.48 last updated October 2, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Vaxcyte.
Vaxcyte does not have any upcoming earnings scheduled.
There is no upcoming split for Vaxcyte.
Vaxcyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
